Orchestra BioMed Hldgs (NASDAQ:OBIO) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.48) by 2.08 percent. This is a 28.95 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $868.00 thousand which beat the analyst consensus estimate of $575.80 thousand by 50.75 percent. This is a 40.00 percent increase over sales of $620.00 thousand the same period last year.